
Alamar Biosciences, Inc.
ALMRHealthcare|Biotechnology|US
$28.05
+1.15 (+4.26%)
DCF Value
$22.60
Tangible Book / Share
$4.37
Cash / Share
$3.28
Next Earnings Report
Feb 2, 2027
EPS est. -$0.28 · Revenue est. $33.2M
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Apr 17, 2026 (424B4). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Alamar Biosciences to Participate in Upcoming Investor Conferences
Nov 4, 2026 · GlobeNewsWire
Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
Nov 3, 2026 · GlobeNewsWire
Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine
Nov 3, 2026 · GlobeNewsWire
UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
Nov 2, 2026 · GlobeNewsWire
Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
Nov 2, 2026 · GlobeNewsWire
Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology
Oct 28, 2026 · GlobeNewsWire
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
Oct 5, 2026 · GlobeNewsWire
Lancet Neurology Study Using Alamar Biosciences' Technology Reveals Divergent Biological Responses to Alzheimer's Treatment
Sep 24, 2026 · GlobeNewsWire
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
Sep 1, 2026 · GlobeNewsWire
SEC Filings (29)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 4, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 3, 2026 | 8-K | Material event | DocumentIndex |
| Sep 1, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 11, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 10, 2026 | 8-K | Material event | DocumentIndex |
| Jul 15, 2026 | 8-K | Material event | DocumentIndex |
| Jul 7, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jul 2, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 8, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 8, 2026 | 8-K | Material event | DocumentIndex |
| Apr 23, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Apr 23, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Apr 20, 2026 | EFFECT | DocumentIndex | |
| Apr 20, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Apr 20, 2026 | 8-K | Material event | DocumentIndex |
| Apr 20, 2026 | POS AM | DocumentIndex | |
| Apr 17, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| Apr 16, 2026 | EFFECT | DocumentIndex | |
| Apr 16, 2026 | S-1MEF | IPO / offering registration | DocumentIndex |
| Apr 16, 2026 | CERT | DocumentIndex | |
| Apr 16, 2026 | S-1/A | IPO / offering registration | DocumentIndex |
| Apr 15, 2026 | 8-A12B | DocumentIndex | |
| Apr 13, 2026 | S-1/A | IPO / offering registration | DocumentIndex |
| Mar 27, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Mar 12, 2026 | DRS/A | DocumentIndex | |
| Feb 17, 2026 | DRS/A | DocumentIndex | |
| Jan 9, 2026 | DRS | DocumentIndex |